Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Ezetrol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,187Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Starts Development of Oral Triple Lipid-Lowering Combo
    Daiichi Starts Development of Oral Triple Lipid-Lowering Combo

    31 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250830562434/en/Daiichi-Sankyo-Announces-the-Initiation-of-the-Development-of-Oral-Triple-Combination-Lipid-Lowering-Tablets-to-Support-the-Management-of-LDL-C

    BUSINESSWIRE
    31 Aug 2025
    Share Share
    ZyVersa Supports Emergency VAR 200 Use in Rare Amyloidosis
    ZyVersa Supports Emergency VAR 200 Use in Rare Amyloidosis

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111633/0/en/ZyVersa-Therapeutics-Supports-FDA-Authorized-Emergency-Compassionate-Use-of-Cholesterol-Efflux-Mediator-VAR-200-in-a-Patient-with-ApoCII-Amyloidosis.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Enforcement Report - Week of June 18, 2025
    Enforcement Report - Week of June 18, 2025

    18 Jun 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-18-2025-14246.pdf

    FDA
    18 Jun 2025
    Share Share
    Scynexis Resumes Patient Dosing in Phase 3 Mario Study
    Scynexis Resumes Patient Dosing in Phase 3 Mario Study

    28 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/28/3089462/0/en/SCYNEXIS-Resumes-Patient-Dosing-in-Phase-3-MARIO-Study.html

    GLOBENEWSWIRE
    28 May 2025
    Share Share
    Menarini Group Announces Positive Obicetrapib Trial Data
    Menarini Group Announces Positive Obicetrapib Trial Data

    16 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/menarini-group-announces-positive-topline-data-from-pivotal-phase-3-broadway--tandem-clinical-trials-evaluating-obicetrapib-and-the-fixed-dose-combination-obicetrapib-with-ezetimibe-10-mg-302332562.html

    PR NEWSWIRE
    16 Dec 2024
    Share Share
    Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US
    Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US

    10 Dec 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211663

    FDA
    10 Dec 2024
    Share Share